Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-23 6:38 pm Purchase |
2024-12-31 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 3,346,743 11.200% |
441,337 (+15.19%) |
Filing History |
| 2024-11-14 4:27 pm Purchase |
2024-09-30 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 2,905,406 11.800% |
13,983 (+0.48%) |
Filing History |
| 2024-10-11 09:42 am Purchase |
2024-09-30 | 13G | Profound Medical Corp. PROF |
LETKO, BROSSEAU & ASSOCIATES INC | 1,198,775 4.900% |
20,925 (+1.78%) |
Filing History |
| 2024-08-05 07:50 am Sale |
2024-07-31 | 13G | Profound Medical Corp. PROF |
BDC Capital Inc. | 1,223,480 4.998% |
-120,699 (-8.98%) |
Filing History |
| 2024-03-13 4:00 pm Unchanged |
2024-03-07 | 13G | Profound Medical Corp. PROF |
DASEKE DON R | 1,105,000 4.500% |
0 (Unchanged) |
Filing History |
| 2024-02-13 4:06 pm Sale |
2023-12-31 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 2,891,423 13.500% |
-245,405 (-7.82%) |
Filing History |
| 2024-02-12 2:37 pm Sale |
2023-12-31 | 13G | Profound Medical Corp. PROF |
LETKO, BROSSEAU & ASSOCIATES INC | 1,177,850 5.500% |
-2,575 (-0.22%) |
Filing History |
| 2024-02-09 07:59 am Sale |
2024-02-08 | 13G | Profound Medical Corp. PROF |
FIL Limited | 1,200,635 5.619% |
-65,090 (-5.14%) |
Filing History |
| 2024-01-11 4:42 pm Purchase |
2023-01-10 | 13G | Profound Medical Corp. PROF |
DASEKE DON R | 1,105,000 5.200% |
1,105,000 (New Position) |
Filing History |
| 2023-02-13 4:05 pm Purchase |
2022-12-31 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 3,136,828 15.000% |
12,464 (+0.40%) |
Filing History |
| 2023-02-10 10:08 am Sale |
2022-12-31 | 13G | Profound Medical Corp. PROF |
Flynn James E | 0 0.000% |
-1,713,797 (Position Closed) |
Filing History |
| 2023-02-09 5:42 pm Purchase |
2022-12-31 | 13G | Profound Medical Corp. PROF |
LETKO, BROSSEAU & ASSOCIATES INC | 1,180,425 5.700% |
1,180,425 (New Position) |
Filing History |
| 2023-02-09 07:57 am Purchase |
2023-02-09 | 13G | Profound Medical Corp. PROF |
FIL Limited | 1,265,725 6.051% |
200,300 (+18.80%) |
Filing History |
| 2023-02-06 4:09 pm Sale |
2022-12-31 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 3,124,364 15.000% |
-57,378 (-1.80%) |
Filing History |
| 2022-10-11 4:10 pm Purchase |
2022-10-06 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 3,181,742 15.300% |
1,103,713 (+53.11%) |
Filing History |
| 2022-03-10 4:05 pm Purchase |
2022-03-08 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 2,078,029 10.000% |
216,810 (+11.65%) |
Filing History |
| 2022-02-14 5:21 pm Sale |
2021-12-31 | 13G | Profound Medical Corp. PROF |
Genesys Ventures II LP | 455,738 2.190% |
-153,745 (-25.23%) |
Filing History |
| 2022-02-11 4:13 pm Purchase |
2021-12-31 | 13G | Profound Medical Corp. PROF |
Flynn James E | 1,713,797 8.250% |
673,376 (+64.72%) |
Filing History |
| 2022-02-09 08:58 am Sale |
2022-02-08 | 13G | Profound Medical Corp. PROF |
FIL Limited | 1,065,425 5.119% |
-79,710 (-6.96%) |
Filing History |
| 2022-02-03 4:31 pm Unchanged |
2021-12-31 | 13G | Profound Medical Corp. PROF |
Gagnon Securities LLC | 1,861,219 9.000% |
0 (Unchanged) |
Filing History |